International Cancer Research Conference
March 24-26, 2025 | Singapore
Immunology and Cancer
Cancer remains a leading cause of mortality globally, and its yearly death toll of 8.2 million people is only anticipated to rise as the world's population ages. The presence of tumor-associated inflammatory cells in cancers poses a critical concern that is one of oncology's most pressing issues. Immunotherapy, which targets the immune system, has revolutionized cancer treatment in the previous decade. Many important questions about the causal relationship between chronic inflammation and carcinogenesis have been answered by immunological tests over the last two decades. Recent clinical and preclinical research has begun to reveal the wide range of systemic immune perturbations that occur during cancer development, and the critical role of peripheral immune cells in the anticancer immune response.
- Onco immunology
- Preclinical Models
- Inflammation
- Carcinogenesis
- Immune Checkpoint Inhibitors (Icis)
- Tumor Microenvironment (TME)
- Immune Therapies
- Peripheral Immune Cells and its Reorganization
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Jianhua Luo
University of Pittsburgh, United States
Patricia Tai
UpToDate, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Tiantian Zhang
University of Central Florida, United States
Priya Hays
Hays Documentation Specialists, LLC, United StatesSubmit your abstract Today
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates